MedVector (Equity)

Funding Details
Awarder
StartEngine
Date Award
July 30, 2021
Vertical
Telemedicine for Clinical Trials
Funding URL
View Funding Page
Premoney Valuation
$10,020,000
Valuation
$10,020,000

Company Info
Founding Year
Not provided
Traction
Currently MedVector has signed NDAs with 9 Pharma/CROs and are analyzing 22 protocols. Things are getting exciting over here! Their new explainer video has been very helpful!
Organizations Involved
Not provided
Founders
Scott Stout, Dr. Dennis J. Patterson
Company Description
MedVector is an industry-first telemedicine platform that greatly accelerates clinical trials. By connecting subjects from anywhere in the world to existing clinical trial sites, MedVector has proven to exponentially increase clinical trial participation and dramatically accelerate FDA approval. Their service generates revenue for doctors and hospitals, reduces costs to clinical trial sponsors, and brings life-changing, advanced medicine to the market more quickly.
Market
Healthcare
Location
El Segundo, CA, US
Coinvestors
Not provided

Links
Back to Home Back to Telemedicine for Clinical Trials Deals View Funding Announcement